×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. I consent to receive medical updates and communications from eMediNexus, it's parent company IJCP and its industry partners.

Dyslipidemia Management in PAD

  946 Views

Dr Raman Puri, New Delhi    19 August 2022

 

  • Peripheral artery disease (PAD) is a highly prevalent atherosclerotic syndrome and is associated with significant disability, morbidity and mortality.
  • PAD still largely remains underdiagnosed, understudied and undertreated.
  • Despite the significant limb and CV outcomes in PAD, there is poor risk factor modification relative to other atherosclerotic diseases like CAD or stroke.
  • Initiate HIS in patients with PAD once diagnosed.
  • Classify the PAD patient in one of the ASCVD risk categories based on related ASCVD risk factors and other comorbidities. Define the goal of LDL-C based on the ASCVD risk category.
  • Send extended lipid profile including LP(a) assessment.
  • If there is a greater reduction of LDL-C required according to the lipid profile report, other nonstatin drugs may be used in addition to HIS.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.